Speaker Abstract RCMM 2017: Mr. Kahlil Lawless

Illumina Next Generation Sequencing is leading a revolution in oncology testing driven by decreasing costs and increasing ease of use in this groundbreaking technology. Here explore examples of how this technology is being applied in pathology labs and updates to the systems and applications that are enabling it, tumor mutation profiling, and cancer risk assessment.